Search - tctmd.com

Displaying 101 - 115 of 115

Sort: Relevancy | Date

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Todd Neale

April 05, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Yael L. Maxwell

March 17, 2015

News Conference News ACC 2015

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Todd Neale

March 15, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

News Conference News ACC 2013

Novel Atherectomy System Helps Treat Severely Calcified Lesions

Jason Kahn

March 08, 2013

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

Video

» Interview

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

May 4, 2022

Advertisement

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Pair of Studies Show Positive Stent Results at ACC

Novel Atherectomy System Helps Treat Severely Calcified Lesions

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content